Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CiPS-BAL in Liver Failure or Small-for-Size Syndrome
NCT07312864Phase 2Recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in liver failure and small-for-size syndrome (SFSS), sponsored by Beijing Friendship Hospital. Primary endpoints: Treatment-Emergent Adverse Events and Serious Adverse Events at Week 4, Survival and Liver Transplantation Rate at Week 4 and 1 more. Started Dec 2025; status: recruiting.
02
Conditions
liver failuresmall-for-size syndrome (SFSS)
Beyond the preview
Go deeper on NCT07312864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07312864.